PD The 1500 is in the active arm The control arm is 15,000 I believe they will select from the control arm to closely match those on the active arm … age , co morbidity etc … especially those that get Covid At the time of the presentation you reference there was a very low event rate in the area they were recruiting in Since then … August I believe … Covid delta wave positivity hit around 20% then subsided Most recent updates is to expect a surge in Covid Omricon from mid Dec thru Jan … in the MITIGATE area .
I think Kaiser will extend this trial if they feel it’s warranted If they don’t get the data they need from the August surge or the expected Omricon surge … then it’s over re Vascepa and Covid benefit
There is already an Omricon variant out break at Kaiser in Oakland
Market Data 
Markets 
AI
